Kevin Lalande

(Mr. Kevin Lalande)

Currently holds positions in Lumos Pharma Inc and Molecular Templates Inc

Positions
Position Company Period
Director Lumos Pharma Inc March 18, 2020 -
Independent Director Molecular Templates Inc Aug. 1, 2017 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-06-21 2022-06-15
B Purchase
62,000 +38.8%
0.89
55,180 USD 		62,000 +38.8% 0.89 55,180 USD
2022-06-21 2022-06-14
B Purchase
60,000 +60.0%
0.87
52,200 USD 		60,000 +60.0% 0.87 52,200 USD
2022-06-21 2022-06-13
B Purchase
100,000 +inf%
0.91
91,000 USD 		100,000 +inf% 0.91 91,000 USD
2020-09-18 2020-09-16
S Sale
500,000 -7.6%
13.05
6,525,000 USD 		500,000 -7.6% 13.05 6,525,000 USD
2020-05-22 2020-05-20
S Sale
300,000 -4.3%
16.51
4,953,000 USD 		300,000 -4.3% 16.51 4,953,000 USD